Navigation Links
K-V Pharmaceutical Announces Resubmission to New Drug Application for Gestiva™
Date:7/13/2010

lings with the SEC.

This discussion is not exhaustive, but is designed to highlight important factors that may impact the Company's forward-looking statements.

Because the factors referred to above, as well as the statements included elsewhere in this press release, could cause actual results or outcomes to differ materially from those expressed in any forward-looking statements made by the company or on the Company's behalf, you should not place undue reliance on any forward-looking statements.  All forward-looking statements attributable to the Company are expressly qualified in their entirety by the cautionary statements in this "Cautionary Note Regarding Forward-Looking Statements" and the risk factors that are included under Part I, Item 1A – "Risks Factors" in the Company's Annual Report on Form 10-K for the fiscal year ended March 31, 2009 and referred to in Part II, Item 1A – "Risk Factors" in the Form 10-Q, as supplemented by the Company's subsequent SEC filings.  

Further, any forward-looking statement speaks only as of the date on which it is made and the Company is under no obligation to update any of the forward-looking statements after the date of this press release.  New factors emerge from time-to-time, and it is not possible for the Company to predict which factors will arise, when they will arise and/or their effects.   In addition, the Company cannot assess the impact of each factor on its future business or financial condition or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements.

Sources:

  1. About Prematurity:  Prematurity Awareness Month – March of Dimes.  1-2.
  2. March of Dime
    '/>"/>

SOURCE K-V Pharmaceutical Company
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Ferring Pharmaceuticals FIRMAGON® Named Official Sponsor of Ed Randalls Bat for the Cure
2. Endo Pharmaceuticals Announces Expiration of Subsequent Offering Period of Tender Offer for HealthTronics, Inc.
3. Alexza Pharmaceuticals Updates Staccato® Pipeline and Outlines Pipeline Development Strategy
4. Jiangbo Pharmaceuticals to Attend Global Hunter Securities China Conference
5. K-V Pharmaceutical Company Receives Letter From New York Stock Exchange Regarding Delayed Filing of Its Annual Report on Form 10-K for Fiscal Year 2010
6. ICAP Ocean Tomo Offers for Sale Advanced Drug Formulation Technology From CyDex Pharmaceuticals Inc.
7. Oramed Pharmaceuticals and sanofi-aventis Enter Into an Agreement for the Insulin Supply of Orameds Oral Insulin Capsules
8. Lotus Pharmaceuticals to Present at Global Hunter Securities 2010 China Conference
9. Federal Appeals Court Rules Pharmaceutical Sales Reps Entitled to Overtime Pay
10. Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Optivar®
11. EUSA Pharma Grants Japanese Rights to Erwinase(R) Oncology Therapy to Ohara Pharmaceutical
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... June 18, 2013  Decision Resources, one of ... pharmaceutical and healthcare issues, announces that its Market ... Middle East and ... the challenges and opportunities to gaining and maintaining ... comprising 24 countries. The countries covered by Market ...
(Date:6/18/2013)... New-generation electronic designs are focused on ... Simultaneously, circuitry is increasing the number of functions ... it performs at. Connecting cables from the active ... such as cameras or detectors, must be small, ... include custom cable designs for high-quality signal and ...
(Date:6/18/2013)... Australia And EMERYVILLE, Calif. ... Pharmaceuticals, Inc. presented final results today from a ... extended release) capsules demonstrating a statistically significant improvement ... from baseline at week 8 versus placebo in ... Adamas, investigational extended-release formulation of amantadine intended for ...
Breaking Medicine Technology:Decision Resources' Market Access Tracker Now Covers the Middle East and Africa 2Decision Resources' Market Access Tracker Now Covers the Middle East and Africa 3Omnetics Circular Connectors Offer Both Micro and Nano Interconnects for Highly Portable Electronic Systems, Meeting the Needs of Designers Looking for Size Reduction Options and Cable Flexibility 2Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 2Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 3Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 4Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 5Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 6
... , SAN DIEGO , Feb. 3 ... that Odysseas D. Kostas , M.D. will join its Board ... Committee.  Dr. Kostas was appointed as the representative of entities affiliated ... to welcome Odysseas to our Board of Directors," said Jack Lief, ...
... , HAMBURG , Feb. 3 ... will be hosting a global teleconference that will: , ... Reveal the results from its symposium in Hamburg being ... globe will convene to develop a comprehensive, evidence-based consensus on the ...
Cached Medicine Technology:ADVENTRX Appoints Icahn Representative to Board of Directors 2ADVENTRX Appoints Icahn Representative to Board of Directors 3The International Negative Pressure Wound Therapy Expert Panel to Announce Results of Inaugural Symposium in Hamburg 2
(Date:6/19/2013)... Tools4ever, a market leader in Identity and Access ... will be giving expert advice on Identity Management infrastructure ... its leading-edge solutions. , IDM 2013 is the ... IDM infrastructure and deployment in the UK. Delegates from ... banking, finance and industry, will be attending the event ...
(Date:6/19/2013)... Bonita ™ Hair Skin and Nail ... to many conditions that range from hair breakage and ... Source® has now developed a single serving, rapid response ... not only stronger than the original Bonita formula, but ... community. , Justin Zehrung, Vice President of Essential ...
(Date:6/19/2013)... The Mesothelioma Victims Center says, "According ... to 3000 citizens, who will be diagnosed with a ... one third will be US Navy Veterans. We can ... exposure form of cancer, or their family members that ... most skilled mesothelioma compensation settlement attorneys, who actually do ...
(Date:6/19/2013)... June 19, 2013 Faith4Kidz is starting a ... equals Peace". Faith4Kidz would like help showing support for kids ... that are more positive. Check out the website, http://www.gracenfaith.com ... The logo is red, white and blue stars as a ... independence throughout history as well as the stars we should ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 Exposed Skin Care ... thousands of acne suffers of all ages finally achieve the ... acne treatment products, this new acne clearing system combines the ... and prevent new acne from forming. , After ... believes these products are some of the most effective available ...
Breaking Medicine News(10 mins):Health News:Essential Source ® Improves On Best Selling Bonita ™ Hair Skin and Nail Product 2Health News:Mesothelioma Victims Center Urges US Navy Veterans Diagnosed With Mesothelioma To Call Them For Instant Access To The Nation's Top Asbestos Lawyers-Better Compensation 2Health News:Mesothelioma Victims Center Urges US Navy Veterans Diagnosed With Mesothelioma To Call Them For Instant Access To The Nation's Top Asbestos Lawyers-Better Compensation 3Health News:Faith4Kidz Introduces Patriotic Hats to Benefit the "Grace in Faith Equals Peace" Mission 2Health News:Exposed Skin Care Review Released by ExposedSkinCareReview.org 2Health News:Exposed Skin Care Review Released by ExposedSkinCareReview.org 3
... artery (ICA) occlusion is frequently associated with severe disability ... carotid artery stenting has been reported, but the safety, ... are not known. ,Stenting is a procedure in ... and advanced to the point of the blockage. The ...
... Manmohan Singh and Union Health Minister Anbumani Ramadoss are to ... the problem of bird flu epidemic. //Awareness of bird flu ... compared to the Western countries. The World Health Organization has ... face if there are any possible flu attack. Dr. Anbumani ...
... from University of Cologne, Germany has found that lowering ... does not increase the risk of disease //progression but ... The results of the study were published in American ... reduced the radiation dosage in patients with early stage ...
... pain is generally considered a problem of adults, rates ... headache - are substantial in adolescents, ranging from 20-50% ... abdominal pain, migraine and tension-type headache are more prevalent ... reproductive hormones are known to be associated with increased ...
... as one of the most neurotoxic plants in western ... myrtifolia are known to be neurotoxic.// This shrub produces ... in the berries. ,Ingestion of few fruits ... including seizures, coma and apnea. ,A recent ...
... Meeting of the American Society for Therapeutic Radiology and ... direct link //between the presence of type II diabetes ... survival rate is worse. ,Researchers at Fox ... of high levels of insulin in the blood and ...
Cached Medicine News:Health News:Pubertal development may predispose women to pain and other symptoms 2Health News:Poisoning by fruits similar to blackberries 2
Femoral selective catheter. Catheter material used is polyurethane (DUCOR). Guidewire campatibility is 0.038". Packaging 5/Box....
Femoral selective diagnostic catheter.The material used is polyurethane (DUCOR). All selective shapes have thrulumen design. Guidewire campatibility is 0.038". Packaging 5/Box....
Femoral selective diagnostic catheter. The material used is nylon (VESTANTM). All selective shapes have thrulumen design. Guidewire campatibility is 0.038". Packaging 5/Box....
... 4F, 5F, and 6F ... is ideal for coronary ... state-of-the-art technology and proprietary ... better responsiveness, optimal torque, ...
Medicine Products: